Our Sites » TechNews TechDatabase Canadian Private Equity Register     Login

Home » VC/PE » DVS Sciences Completes Series A Financing

DVS Sciences Completes Series A Financing

DVS Sciences, Inc., an analytical equipment and reagents development company, has secured a tranched US $14.6 million Series A round of financing led by 5AM Ventures with participation from Mohr Davidow Ventures (MDV), Pfizer Venture Investments (PVI), and Roche Finance Ltd.

In conjunction with the financing, Andrew J. Schwab, founder and Managing Partner of 5AM Ventures, and Willaim (Bill) Burkoth, Senior Director of Pfizer Ventures, have joined DVS’ board of directors.

Markham, Ontario DVS Sciences, a University of Toronto spinoff, was seed funded by The Ontario Institute for Cancer Research (OICR) .


Copyright © 2013 TechFinance.ca. All rights reserved. | Healthy Living | wp-tips.
More in VC/PE (174 of 250 articles)